To investigate whether DEP is also capable of binding to endogenous PPARγ directly in living cells, we performed a targeted competitive proteomics experiment in Caco-2, a colon cancer cell line known to express larger amounts of PPARγ49. This evidence concerns the gene PPARG and colonic neoplasm.